Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Want to use multi-omics data to examine different genetic pathways underlying cancer, but you lack the necessary coding experience? Meet MOPAW, a new point-and-click interface that can help you make the most of your genetic data.

In a recent study, NCI’s Dr. Haoyu Zhang describes CT-SLEB—a powerful and computationally scalable method for generating more precise polygenic risk scores across a range of ancestral groups (including Latino, African American, East Asian, and South Asian).

We’re seeking a qualified biomedical informatics specialist to join our CBIIT Team. Apply today for this unique opportunity to use data-driven approaches for advancing cancer research.

If you’re using data science to do genomics research for preventing, detecting, and treating cancer across diverse populations, see if this NCI-supported funding opportunity is for you.

NHGRI’s Dr. Andy Baxevanis is recruiting a postdoctoral fellow to develop and apply bioinformatic approaches to large-scale genomic data sets, focusing on the evolution of specific protein families and biological pathways that have putative roles in disease causation.

The Integrative Tumor Epidemiology Branch of the NCI Division of Cancer Epidemiology and Genetics wants to fill multiple doctoral bioinformatics scientist positions.

See if this job doing computational biology for cancer research is a good fit for you!

The PLCO Atlas allows investigators to browse and access germline genetic association data from the PLCO Screening Study via the Genome-Wide Association Study Explorer.

Researchers seeking potential targets for treating childhood cancers now have an even better tool for the job. Check out the latest enhancements to the NCI Childhood Cancer Data Initiative’s (CCDI’s) Molecular Targets Platform.

NCI-funded researchers validated a genome-wide artificial intelligence technology that could help in early detection of hepatocellular carcinoma—the most common type of liver cancer.